iTonic Ltd. (ITOC)
NasdaqCM: ITOC
· Real-Time Price · USD
0.30
+0.01 (3.45%)
At close: Aug 12, 2026, 11:14 AM
iTonic Ltd. (ITOC) Stock Price, Analysis & Data
3.45% (1D)
| Bid | 1.15 |
| Market Cap | 7.45M |
| Revenue (ttm) | 523.03K |
| Net Income (ttm) | -5.1M |
| Beta | n/a |
| EPS (ttm) | -0.32 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| P/B (ttm) | 0.84 |
| P/S (ttm) | 14.25 |
| Earnings Date | n/a |
| Ask | 1 |
| Volume | 31,844 |
| Avg. Volume (20D) | 857,180 |
| Open | 0.30 |
| Previous Close | 0.29 |
| Day's Range | 0.29 - 0.31 |
| 52-Week Range | 0.22 - 1.18 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ITOC
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malig...
Industry Medical Devices
Sector Healthcare
IPO Date Sep 5, 2024
Employees 7
Stock Exchange NasdaqCM
Ticker Symbol ITOC
Website https://www.ftzy.com.cn
Financial Performance
In 2025, iTonic's revenue was 523.03K, an increase of 16.7% compared to the previous year's 448.2K. Earnings were -5.1M, an increase of 671.72%.
Financial Statements